Skip to content

Cart

Your cart is empty

Article: Liposomal CoQ10: Ubiquinone, Absorption and the Evidence

Liposomal CoQ10: Ubiquinone, Absorption and the Evidence

Liposomal CoQ10: Ubiquinone, Absorption and the Evidence

Coenzyme Q10 is one of the most researched compounds in the supplement category and one of the most difficult to formulate. Both facts come from the same source: it is a large, fat-soluble molecule that the body makes for itself and absorbs from food poorly.

What coenzyme Q10 is

CoQ10 is a benzoquinone with a long isoprenoid tail. That tail is what makes it lipophilic, and it is why the molecule sits inside membranes rather than dissolving in the watery compartments around them.

Its best-described location is the inner mitochondrial membrane, where it functions as an electron carrier in the respiratory chain, shuttling electrons between complexes. It also exists in a reduced state that participates in redox chemistry within lipid membranes.

The body synthesises CoQ10 endogenously through a pathway that shares early steps with cholesterol synthesis. Dietary intake from foods such as oily fish, organ meats and some oils is comparatively small, typically estimated in the low milligrams per day.

Tissue concentrations have been observed to differ with age and across various clinical populations. 

Ubiquinone and ubiquinol

The two names describe the same molecule in two oxidation states.

Ubiquinone is the oxidised form. It is chemically stable, easier to manufacture and easier to keep stable in a finished product

Ubiquinol is the reduced form. It is less stable in air and requires more protective formulation

The commercial argument for ubiquinol rests on the idea that it is closer to the form found in circulation. The counter-argument is that the body interconverts the two forms readily, and that ubiquinone appears to be reduced to ubiquinol during or after absorption. Comparative human bioavailability studies between the two forms exist and do not point in a single direction.

For a formulator, ubiquinone offers a meaningful practical advantage: it holds up better over a product's shelf life, which is not a trivial consideration for a molecule this sensitive.

Why absorption is the whole conversation

CoQ10 has a molecular weight around 863 and is essentially insoluble in water. Absorption depends on the same lipid handling machinery that processes dietary fat: bile salts, micelle formation, then packaging into chylomicrons and entry via the lymphatic system.

That pathway is inefficient and highly variable. Published estimates of oral bioavailability for unformulated crystalline CoQ10 sit at a very low percentage of the dose, and it is well documented that taking it with a fat-containing meal changes absorption substantially.

Formulation approaches to this problem have included solubilised soft gels, self-emulsifying systems, crystal-free preparations and phospholipid encapsulation. A liposomal approach presents the molecule already integrated into a phospholipid structure, which is closer to the physical state the absorption pathway is built to handle.

The honest framing: this addresses a genuine and well-characterised pharmaceutical problem. It does not by itself demonstrate a clinical outcome.

What the research has investigated

CoQ10 has been studied across a wide range of contexts. Reporting that accurately, and without conclusions, matters here.

Investigation has clustered around cardiovascular research, where Q-SYMBIO is the most cited randomised trial, around statin-associated muscle symptoms, around measures of oxidative stress, and around fertility and mitochondrial biology.

Dose and practical considerations

Formulations on the UK market commonly range from 30 mg to 300 mg per serving.

Taking CoQ10 with a meal containing fat is consistent with what is understood about its absorption pathway. Splitting larger amounts across the day has been suggested on the basis of saturable absorption, though this is a pharmacokinetic inference rather than a trial-tested protocol.

CoQ10 is structurally similar to vitamin K, and there is a documented interaction with vitamin K antagonist anticoagulants such as warfarin. Anyone taking anticoagulant medication, or any prescribed medicine, should speak to their GP or pharmacist before starting CoQ10.

Common questions

Is ubiquinol better absorbed than ubiquinone? Human comparison studies exist and do not consistently favour one form. Formulation and the fat content of the meal appear to influence absorption more than oxidation state does.

Why do CoQ10 doses vary so widely between products? Because absorption varies so widely between formulations. A stated milligram figure describes what is in the capsule, not what reaches circulation.

Should CoQ10 be taken with food? Absorption is lipid dependent, so taking it with a meal containing fat is consistent with the mechanism.

Does CoQ10 interact with medication? There is a documented interaction with vitamin K antagonist anticoagulants. Check with a pharmacist or GP.

Why is CoQ10 associated with statins in so many articles? Statins inhibit an enzyme in a pathway that also contributes to endogenous CoQ10 synthesis. The clinical significance of this has been studied and remains contested.

References

  1. Crane FL. Biochemical functions of coenzyme Q10. Journal of the American College of Nutrition. 2001;20(6):591-598.
  2. Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Research. 2006;40(5):445-453.
  3. Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion. 2007;7 Suppl:S78-S88.
  4. Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO, a randomised double-blind trial. JACC: Heart Failure. 2014;2(6):641-649.
  5. Banach M, Serban C, Sahebkar A, et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomised controlled trials. Mayo Clinic Proceedings. 2015;90(1):24-34.
  6. Taylor BA, Lorson L, White CM, Thompson PD. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy. Atherosclerosis. 2015;238(2):329-335.
  7. López-Lluch G, Del Pozo-Cruz J, Sánchez-Cuesta A, et al. Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition. 2019;57:133-140.
  8. Great Britain Nutrition and Health Claims Register. Department of Health and Social Care, gov.uk.

Food supplements are not a substitute for a varied and balanced diet and a healthy lifestyle.